Cannabis in Portugal

Cannabis in Portugal

The medical cannabis market continues to develop at a slow pace. The introduction of the first flower at the start of 2021 was not enough to propel the emergence of other medications in 2022. However, cannabis companies continue to rise in Portugal and invest in their production centres, despite their focus being on exports and not on the local market. In any case, proposals for the legalisation of adult-use cannabis were addressed to the parliament once again in 2022...

Euromonitor International's Cannabis in Portugal market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2026 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.